Note: The statement that no clinical trial results compare Eliquis with Xarelto for stroke risk reduction is the manufacturer's, as captured on November 12, 2026.
Eliquis vs Xarelto in adults 65 and older: what did real-world data show (Dawwas 2025)?
Note: The hazard ratios compare patients who switched from Eliquis to Xarelto with patients who continued Eliquis; in the leave-behind charts, switchers had the higher incidence (stroke/SE 1.53 vs 0.75, major bleeding 4.59 vs 2.44 per 100 person-years).